Personalis CFO Aaron Tachibana Sells Shares
Aaron Tachibana, CFO and COO of Personalis, Inc., sold 51,251 shares on June 26, 2026.
Key Points
- Aaron Tachibana, CFO and COO of Personalis, Inc., sold 51,251 shares on June 26, 2026.
- Shares of Personalis traded near $13.02 on Saturday, with a 52-week range of $3.84 to $13.37.
- Morgan Stanley maintained a hold rating on Personalis with a $9.00 target on May 12, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Aaron Tachibana, the Chief Financial Officer and Chief Operating Officer of Personalis, Inc. (NASDAQGM: PSNL), sold 51,251 shares of the company on June 26, 2026. This transaction was not part of a pre-planned trading program.
Insider Buying and Selling at Personalis, Inc.
On June 26, 2026, Aaron Tachibana, CFO and COO of Personalis, Inc., executed a sale of 51,251 shares. The sale was not conducted under a Rule 10b5-1 plan. Additionally, Christopher Hall, the CEO of Personalis, also sold 100,000 shares on the same day, with some transactions being planned and others not.
Personalis, Inc. Stock Down 23.7%
Shares of Personalis, Inc. traded near $13.02 on Saturday. The company's market capitalization stands at approximately $1.36 billion. Personalis has a forward P/E ratio of -14.54, indicating it is not currently profitable. The stock has experienced a 52-week range between $3.84 and $13.37, with a 50-day moving average of $8.27 and a 200-day moving average of $8.21. The company maintains a strong liquidity position with a current ratio of 6.61 and a quick ratio of 6.31.
$PSNL stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On May 12, 2026, Morgan Stanley maintained its hold rating on Personalis with a price target of $9.00. BTIG also maintained a buy rating with a target of $11.00 on May 11, 2026. The consensus among seven analysts is a hold rating with an average target price of $10.86.
About Personalis, Inc.
Personalis, Inc. is a healthcare company based in Fremont, California, specializing in advanced cancer genomic tests and services. It offers products like the NeXT Personal liquid biopsy test and ImmunoID NeXT, which provide detailed insights into cancer tumors. The company collaborates with pharmaceutical firms for research and clinical trials and employs around 259 people under the leadership of CEO Christopher M. Hall.
Bottom Line
Aaron Tachibana's recent sale of shares highlights insider activity at Personalis, Inc. Investors often track such transactions for insights into company leadership's confidence. While shares traded near their 52-week high, analysts have mixed views, with targets ranging from $9.00 to $13.00. As always, remember that insider transactions are backward-looking and may not indicate current strategies.
Get Personalis, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PSNL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.